WASHINGTON — Timing matters when it comes to combining immunotherapy with chemoradiation in limited-stage small cell lung cancer (SCLC), according to the phase 3 NRG-LU005 trial […]

WASHINGTON — A phase 2 study has demonstrated encouraging results for lutetium-177 (177Lu) dotatate in patients with surgery- and radiation-refractory meningioma. Kenneth Merrell, MD, MS, presented […]

About 40% of patients with brain metastases who experienced cognitive decline after brain radiation therapy regained full cognitive function within 6 months following treatment, a new […]

BARCELONA, Spain — Trastuzumab deruxtecan (TDXd) shows promise as a treatment for HER2-low and HER2-ultralow hormone receptor (HR)–positive metastatic breast cancer, according to data from the […]

Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, […]

Hypofractionated (HF) whole-breast irradiation with simultaneous integrated boost (SIB) can be considered a standard of care for adjuvant radiotherapy after breast conserving surgery, new data suggests. […]

Fantine Giap, MD, sat across from a 21-year-old with a rare sarcoma at the base of her skull.  Despite the large tumor, nestled in a sensitive […]

BARCELONA — The oncologist’s goal is to provide cancer patients with the most effective and least toxic treatment available. For patients with brain metastases, whole-brain radiotherapy […]

WASHINGTON, DC — Radiation oncologists can feel confident offering hypofractionated treatment regimens to treat breast cancer in patients who are planning breast reconstruction after mastectomy, following […]